Clinical Trial Update: Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease

View source ↗

Summary

A recruiting clinical trial is comparing guselkumab to ustekinumab for Crohn's disease with intestinal strictures, sponsored by Zhejiang University's Second Aff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease

Drugs mentioned

• Guselkumab (Tremfya) (guselkumab)
• Ustekinumab (Stelara) (ustekinumab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: CD - Crohn's Disease, Stricture; Bowel | Status: RECRUITING